SYNGEN BIOTECH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

23/02/2000

VAT status

Active

Bankruptcy proceedings

No proceedings

SYNGEN BIOTECH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ

Contacts

Registered address

See on map

Website

WWW.SYNGEN.PL

Average

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Incorporation date

18/07/2022

Share capital

50,000.00 PLN

Primary activity

Retail sale of medical and orthopaedic goods in specialized stores (47.74.Z - PKD 2007)

Representatives

Representatives rights

W PRZYPADKU ZARZĄDU JEDNOOSOBOWEGO OŚWIADCZENIA W IMIENIU SPÓŁKI SKŁADA CZŁONEK ZARZĄDU. W PRZYPADKU ZARZĄDU SKŁADAJĄCEGO SIĘ Z DWÓCH LUB WIĘKSZEJ ILOŚCI OSÓB DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI WYMAGANE JEST WSPÓŁDZIAŁANIE DWÓCH CZŁONKÓW ZARZĄDU ALBO JEDNEGO CZŁONKA ZARZĄDU ŁĄCZNIE Z PROKURENTEM.

Representatives

Chairman of the management boardM********* V******* C*********-Z*****

Business linkages

Price: zł63.00
Premium users: 1.00 credit

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

People

Representatives

Person	Title
M******* V*** C*****-Z***	Chairman of the management board

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

1,248,345

Net Profit (zł)

1,248,345

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2022
10,532,009
2,069,047
1,665,766
0.60
22.89
15.82
6,376,019
287,254
0
87,358

2023
8,519,574
2,124,771
1,715,836
0.91
32.89
20.14
8,090,857
243,885
-
313,283

2024
9,448,010
1,553,193
1,248,345
0.97
20.13
13.21
9,339,201
479,024
-
-

2024
9,448,010
1,553,193
1,248,345
0.97
20.13
13.21
9,339,201
479,024
-
-

Turnover (zł)

2024

Turnover (zł)

9,448,010 zł11 % *

Profit before tax (zł)

1,553,193 zł-27 % *

Net Profit (zł)

1,248,345 zł-27 % *

Working capital requirement (%)

0.97 6.59 % *

Liquidity ratio

20.13 -38.80 % *

Net profitability (%)

13.21 %-34.41 % *

Equity (zł)

9,339,201 zł15 % *

Current liabilities (zł)

479,024 zł96 % *

Non current liabilities (zł)

Non-current Assets (zł)

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Price: 1.00 credit

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

SYNGEN BIOTECH SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ Documents

Date	Description
16/06/2025	OD 01.01.2024 DO 31.12.2024
10/07/2024	OD 01.01.2023 DO 31.12.2023
12/07/2023	OD 01.01.2022 DO 31.12.2022